AusBiotech

Members are invited to attend the annual general meeting (AGM) of AusBiotech Ltd, which will be held at the AusBiotech 2018 national conference at the Brisbane Convention and Exhibition Centre on Wednesday 31 October 2018 at 12.30pm.

Just two weeks left to be nominated for this year’s AusBiotech and Johnson & Johnson Industry Excellence Awards. The industry awards will be presented at AusBiotech 2018 in Brisbane, recognising the highest achievers in the Australian life sciences.

Research Australia’s annual survey of views on health and medical research, Australia Speaks!, shows Australians continue to place improving hospitals and healthcare as the number one spending priority for the Australian Government - ahead of infrastructure, education standards and employment opportunities.

Reform to the laws on equity sourced crowdfunding are expected to be passed in the Parliament this week to include 'eligible proprietary companies'.

AusBiotech has submitted comment on behalf of members to consultations on the ‘Intellectual Property Laws Amendment Bill (Productivity Commission Response Part 2 and Other Measures) 2018’ and to inform the second Australian Medical Research and Innovation Priorities 2018 – 2020 for the Medical Research Future Fund (MRFF).

A record gathering yesterday saw the opening of the AusBiotech AusAg & Foodtech Summit 2018, which is about translating Australian science into business by putting the spotlight on investment in agritech and foodtech innovation.

With online submissions open on the Australian Medical Research and Innovation Priorities 2018–2020 until 31 August 2018, interested parties are invited to comment.

The J&J Lung Cancer Innovation QuickFire Challenge will award up to $750,000 in non-dilutive grant funding and one year of optional residency at the new JLABS@Shanghai for game-changing, outside-the-box solutions addressing the prevention, interception and cure for lung cancer.

In recognition of ongoing issues of fragmentation and inefficiency that impact on Australia’s attractiveness as a preferred location for clinical trials, a new Governance Framework is under development as a first step toward a nationally-consistent accreditation for health services undertaking clinical trials.

The TGA has engaged CSIRO to conduct research to build an understanding of Australia’s innovation in ‘software as a medical device’.

The latest INSEAD Global Innovation Index (2018, Energizing the World with Innovation) ranks Australia 20 overall, up from 23 last year - showing that Australia has seen little improvement on these global measures.

Companies are urged to provide feedback on the definition of clinical trials under yet-to-be legislated reforms to the R&D Tax Incentive.